Medical Developments International Limited (ASX: MVP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medical Developments International Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medical Developments International Limited (ASX: MVP)
Latest News
Share Market News
These 3 ASX shares would have doubled your money in 12 months
Share Market News
Paradigm Biopharmaceuticals shares have skyrocketed. Should you invest?
Share Market News
Why this growing ASX healthcare company should be on everyone's watch lists
Share Market News
This ASX healthcare share skyrocketed last week. Should you invest?
⏸️ Best ASX Shares
Happy Australia Day!
Healthcare Shares
2 ASX biotech shares that could be the next CSL
Healthcare Shares
2 ASX healthcare shares to buy and hold until 2025
Record Highs
Why IDP Education, Medical Developments, & REA Group just hit record highs
Share Market News
4 ASX shares on my 2020 watchlist
Healthcare Shares
2 ASX healthcare shares I wish I'd owned in 2019
⏸️ Investing
Can the Medical Developments share price double again in 2020?
Share Gainers
Why Adairs, Medical Developments, Nuchev, & Worley are storming higher
Frequently Asked Questions
-
Medical Developments International has not paid a Dividend since 2019.
-
Medical Developments International Ltd listed on the ASX on 15 December 2003.
MVP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medical Developments International Limited
Medical Developments International Ltd (ASX: MVP) is an Australian- based pharmaceutical company. It manufactures and distributes pharmaceutical drugs covering pain management, asthma, and resuscitation, as well as medical and veterinary equipment.
The company has three business units: pharmaceuticals, medical devices, and veterinary products. The majority of its revenue comes from its pharmaceuticals segment which produces and sells the pain relief drug Penthrox within Australia, New Zealand, and the United Kingdom, as well as some sales in other countries.
